Singapore's Shadow Plague: A 300% Riluzole Rocket Reveals mRNA's Motor Neuron Mayhem, By Mrs (Dr) Abigail Knight (Florida)

Singapore — the COVID cracks are spiderwebbing. What began as a triumph of tech-enforced vaccination (92% uptake, no fakes, all tracked via SingPass) has morphed into a quiet horror show. Excess deaths? Skyrocketing to 37% above baseline by 2023, fourfold the official COVID toll. Case fatality rates? Climbing 60% post-rollout despite a tamer virus. And now, the canary in the coal mine: Riluzole sales, the lifeline for ALS (amyotrophic lateral sclerosis, or motor neuron disease), exploding 300% since the mRNA blitz. This isn't market hype for a trendy pill; it's a 30-year-old staple screaming more patients, more paralysis, more graves.

Blogger Aussie17, a Big Pharma veteran with two decades spinning sales yarns for the top houses, dropped this grenade on October 14. No tinfoil screed, just raw distributor data, trend lines crunched personally, and a pharma insider's nose for "off" smells. "It's a slow-burn health crisis," they warn, "slipping right past the mainstream." I've dug deeper: The verdict? It's not coincidence. It's consequence. mRNA's spike protein, laced with contaminants, didn't stay in the arm, it breached the blood-brain barrier, kindling a motor neuron inferno. Time to dust off The Walking Dead scripts; this zombie march is real, and Singapore's the ground zero.

Forget Australia's fake-cert chaos or Europe's opt-outs. Singapore's SingPass ecosystem, mandatory for everything from banking to breathing, locked in compliance like a vice. Rollout? December 20, 2020, weeks after FDA greenlight, fuelled by a $250 million BioNTech stake. Green tags for the jabbed, red for resisters: malls, offices, eateries, all gated. Result: 87.8% mRNA uptake (Pfizer/Moderna), 92% full vax by 2022. No loopholes, no shadows.

Early batches? The tainted ones, now infamous for plasmid DNA and SV40 promoters, per CDC's September 2025 ACIP confessions. Aussie17 nails it: "First dibs on the initial Pfizer batches... getting shredded in labs." And the payoff? Pre-vax CFR: 0.05% (58k cases, 29 deaths). Post-rollout: 0.08% (2M+ cases, 1,682 deaths in 2022 alone). A 60% lethality hike with Omicron's whimper. Singapore? Zero kid "saves," yet a generation primed for payback.

Enter Cedric Lim: cabbie, sceptic, Telegram poster in Iris Koh's "Healing the Divide." Books Sinovac to keep his job, still gets raided, no warrant, cops growling threats. SingPass snitched his every move; he's "Patient Zero" in the fake-jab witch hunt. Jab-or-job dystopia, digitised. Aussie17's right: "Gotta catch 'em all." But the real catch? A populace dosed early, often, with unvetted gene tech.

Our World in Data paints it stark: Flat excess mortality pre-vax (2020's COVID dip barely dents). Then Q3 2021, mRNA peak, red line surges. By Q2 2023, Singapore crowns global excess death charts at 37% over trend, cumulative 9,000+ vs. 2,000 COVID fatalities. Mortality.watch ranks it top-quartile among vax-heavy nations. Swiss Re's 2023 autopsy? 39% cardiovascular excess, 35% respiratory, 10% cancer — non-COVID killers spiking post-jab.

Frontiers in Public Health logs 24.23% percent excess mortality (PEM) post-zero-COVID shift, Delta-timed. BMJ's 2024 sweep: Western excess persists three years running. And a 2025 PMC study? Sustained all-cause spikes in 21 countries, vaccination efforts oddly tied to higher 2022 mortality in some cohorts. Coincidence? Or hybrid harms, lingering spike producing reinfections into organ collapse? Singapore's the bellwether: hyper-vaxxed, data-pure, death-surge poster child.

ALS: The thief that strips motor control, twitching to wheelchair to ventilator in 2-5 years. Riluzole (Rilutek in Singapore)? Glutamate blocker, ekes 2-6 months survival. Pre-2020 sales? Snooze: 8k-14k boxes quarterly, steady as she goes. COVID? Barely blips. Then Q2 2021 —vax crescendo —sales climb: 22k by Q3, 30k-37k by 2025. 300%+ surge, glued high. No generics muddying (Singapore's market too small), no ad blitz, just demand. Raw boxes, not bucks.

Aussie17's proprietary distributor pulls? Gold. Iris Koh's October 2025 echo: "Pharma sales GOING UP post-Covid... Riluzole spiked 300% after vaccination." Global market? Cognitivemarketresearch pegs Singapore Riluzole revenue at $7.66M (2025 est.), up from baselines, but that's aggregate, ignoring the patient influx. ALS incidence? Stable historically (2-3/100k). Better diagnostics? Laughable in a 50x27km surveillance state with 100% access.

Japan? 540% Riluzole jump 2021-2022, yen data through 2022. Australia? Muddier (generics), but creeping 20-30% post-2020, lagging vax zeal. Pattern: Dose density = disease density.

Crunch: New patients, not restocks, ALS's timeline devours users fast. Wave of diagnoses, post-jab.

Plausible? CDC's ACIP 2025 bombshell: mRNA lipids cross blood-brain barrier, spike in neurons, eyes, hearts. Frameshifting? 10% "Frankenstein" proteins. SV40 DNA? Genomic roulette. Prions? Misfolds mimicking mad cow.

Cases mount: PMC's 2023 report, new-onset ALS post-J&J. ResearchGate October 2025: Motor neuron disease after Sinopharm. Frontiers 2022: Neuromuscular hits post-mRNA, ipsilateral to injection. MDPI 2024 hedges "vaccination preventive," but concedes overlap with long-COVID "spikeopathies." Springer 2025: ALS genetics meet environmental triggers, spike fits.

Cleveland Clinic? More jabs = more infections, nuking viral-blame. Hybrid harms redux: Persistent spike primes neurons for prion-like doom. Riluzole's the mop-up; the spill's mRNA.

Aussie17's clarion isn't hype, it's harbinger. Singapore's data purity unmasks what fuzzy stats hide elsewhere: mRNA's long tail, twisting motors into mush. 300% Riluzole? Not salesmanship; suffering. Excess graves? Not "living with COVID"; laced with spike.

This demands: Halt boosters. Audit brains via autopsy spikes. Probe contaminants, SV40 trials, now. And accountability: BioNTech investors, SingPass architects, ACIP dawdlers. Cedric Lim's raid? Symptom of a system that jabbed first, asked questions never.

The Walking Dead? Fiction. Singapore's shuffle? Fact. Heed Aussie17: "Stay away from highly vaccinated areas." Or better: Demand the detox. The Smart Nation's dimming; time to unplug the lie.

https://www.aussie17.com/p/the-jab-that-keeps-on-giving300-increase